Displaying items by tag: division of nephrology

Anupam Agarwal, M.D., Donny Burke, Ph.D., Maj. Gen. Lee Price (retired), Doug Rigney, Ph.D., and Jerry Stephens, Ph.D., were honored by the NAS.
Immune system cells and a drug used for treating rheumatoid arthritis will be studied in an effort to reduce inflammation in kidney transplants and improve long-term function.
Consuming fried foods and sugar-sweetened beverages is linked to a 50 percent increase in risk of death, according to a new study in the American Journal of Kidney Diseases.
Physicians and staff spent three days and nights in-hospital during the South’s recent winter storm to ensure success of a kidney transplant chain that stands at 13 and counting.
Preparation for an innovative, complex UAB program has been years in the making, and up to 30 “hard-to-match” patients are expected to receive organs this year.
Change in key protein unleashes natural defense against major kidney disease mechanism.

Agarwal’s appointment follows the Feb. 8, 2013, selection of former Dean and Senior Vice President Ray L. Watts, M.D., as the seventh president of UAB.

Synthetic marijuana, known as SPICE or K2, does not show up in drug screens but can negatively impact kidney function.

Renal replacement therapy performed continuously over 24 hours provides better hemodynamic tolerance, fluid removal in critically ill patients with kidney failure.

You’d have to drink 10 glasses of milk a day to get your recommended vitamin D, UAB experts say. Sunshine or a supplement is better.

Newer, less used risk predictor for diagnosing kidney disease is better, costs same as more common, less accurate test.
Identifying key protein interactions in cast nephropathy could aid in drug development for deadly myeloma complication.

The event will be a day of collaboration among faculty, clinicians, postdocs and students with an interest in basic and clinical immunology.

UAB researchers have published a paper showing a link between micro-organisms and a type of kidney disease.

New drug may slow the progression of chronic kidney disease in type 2 diabetics, increase kidney function and stave off dialysis.

Adding cystatin C to a diagnostic panel revealed one person in six who had chronic kidney disease that was undetected using the conventional test.

Page 4 of 4